middle.news
Elixinol’s margins strengthen as Vitable deal reshapes its Australian growth plan
8:29am on Wednesday 14th of October, 2026 AEDT
•
Health and Wellness
Read Story
Elixinol’s margins strengthen as Vitable deal reshapes its Australian growth plan
8:29am on Wednesday 14th of October, 2026 AEDT
Key Points
Q3 sales revenue rose 6% to A$3.6 million
Gross profit increased 27% to A$1.5 million
Gross margin expanded to 42% from 35%
Underlying operating cash flow was positive for the fourth consecutive quarter
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Elixinol Wellness (ASX:EXL)
OPEN ARTICLE